Protara Therapeutics, Inc. Ratios

Ratios Dec2013 Dec2014 Dec2015 Dec2016 Dec2017
Profitability
EBT Margin 926.71%-315.26%
EBIT Margin 827.18%-257.12%
EBITDA Margin 919.05%-113.57%
Operating Margin 827.18%-257.12%
Net Margin 1,629.62%-328.87%
FCF Margin 774.33%-340.60%
Efficiency
Invested Capital 82.46M
Leverage & Solvency
Interest Coverage Ratio -8.27-8.84
Equity Ratio 0.97
Times Interest Earned -8.27-8.84
Valuation
Enterprise Value 108.20M255.67M31.53M33.48M
Market Capitalization 191.80M255.67M31.53M33.48M
Return Ratios
Return on Sales 9.27%-3.15%